Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Those wins sit next to real problems: advertising games, an intrusive intake, AI-heavy support, pharmacy ambiguity, delayed tracking notifications, and a BBB F rating that echoes the issues we hit ourselves
The programme spans multiple trials targeting distinct endpoints: On 21 May 2026 Eli Lilly reported topline results from TRIUMPH-1, the pivotal Phase 3 obesity trial and the programme's first Phase 3 efficacy readout: in 2,339 adults, mean weight loss at the 80-week primary endpoint reached 19.0% (4mg), 25.9% (9mg), and 28.3% (12mg) versus 2.2% for placebo (Eli Lilly investor release
Patients with liver problems: The medication should also be used cautiously in patients with liver problems, necessitating regular monitoring of liver function
Gibson continues
Patient researchers who respect the titration schedule generally report much better experiences than those who try to accelerate to higher doses
Protect from light UV exposure degrades peptides
